Syntheses and biological evaluation of new fluoroquinolone antibacterials containing chiral oxiimino pyrrolidine

Bioorganic and Medicinal Chemistry Letters

Volumn 14, Issue 5, 2004, Pages 1273-1277

  Choi, Dong Rack ^a   Shin, Jung Han ^a   Yang, Jin ^a   Yoon, Sue Hye ^a   Jung, Yong Ho ^a  

^a DongWha Pharm Ind Co   (South Korea)

Author keywords

Antibacterial activity; Fluoroquinolone; Oxiimino pyrrolidine

Indexed keywords

FUNCTIONAL GROUP; OXIIMINOPYRROLIDINE; PYRROLIDINE DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; DRUG ACTIVITY; DRUG DESIGN; DRUG SCREENING; DRUG SYNTHESIS; IN VITRO STUDY;

EID: 1242339014     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2003.12.044     Document Type: Article

References (18)

1. Koga H., Itoh A., Murayama S., Suzue S., Irikura T. J. Med. Chem. 23:1980;1358.
2. Peterson, L. P. Quinolone Resistance in Clinical Practice: Occurrence and Importance. In Quinolone Antibacterial Agents, 2nd ed.; Hooper, D. C., Ed. American Society for Microbiology: Washington, DC, 1993; p 119.
3. Moellering, R. C., Jr. Quinolone Antimicrobial Agents; Overview and Conclusions Ibid. pp 527-535.
4. Cecchetti V., Fravolini A., Lorenzini M.C., Tabarrini O., Terni P., Xin T. J. Med. Chem. 39:1996;436.
5. Jaynes B.H., Dirlam J.P., Hecker S.J. Annu. Rep. Med. Chem. 31:1996;121.
6. Chu D.T.W. Annu. Rep. Med. Chem. 33:1998;141.
7. Ma Z., Chu D.T.W., Cooper C.S., Li Q., Fung A.K.L., Wang S., Shen L.L., Flamm R.K., Nilius A.M., Alder J.D., Meulbroek J.A., Or Y.S. J. Med. Chem. 42:1999;4202.
8. Cooper C.S., Klock P.L., Chu D.T.W., Hardy D.J., Swanson R.N., Platter J.J. J. Med. Chem. 35:1992;1392.
9. Nakano, J.; Fukui, H.; Haigoh, H.; Senda, H.; Iwatani, W.; Arika, T. E.P. 0541086, Dec 5, 1993.
10. Hong C.Y., Kim Y.K., Lee Y.H., Kwak J.H. Bioorg. Med. Chem. Lett. 8:1998;221.
11. Hong C.Y., Kim Y.K., Chang J.H., Kim S.H., Choi H., Nam D.H., Kim Y.Z., Kwak J.H. J. Med. Chem. 40:1997;3584.
12. Suto M.J., Domagala J.M., Roland G.E., Mailloux G.B., Cohen M.A. J. Med. Chem. 35:1992;4745.
13. Coupling glycine ethylester hydrochloride with ethyl acrylate in the presence of triethylamine, Cbz protection and potassium tert-butoxide assisted cyclization can give the indicated starting material 1 (1-benzyl 3-ethyl 4-oxo-1,3-pyrrolidinedicarboxylate).
14. All cultures were obtained from Hoechst and MICs were determined by the agar dilution method as recommended by the National Committee for Clinical Laboratory Standards.
15. 14: 7-(3-Aminomethyl-4-methoxyimino-3-methyl-piperidin-1-yl)-1- cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid hydrochloride, 15: 7-(3-Aminomethyl-4-benzyloxyimino-3-methyl-pyrrolidin-1-yl)- 1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid hydrochloride, 16: 7-(4-Aminomethyl-4,8,8-trimethyl-7,9-dioxa-2-aza-spiro[4.5] dec-2-yl)-1-cyclopropyl-6-fluoro-4oxo-1,4-dihydro-[1,8]naphthyridine-3- carboxylic acid hydrochloride.
16. 3, Radiation=Mo Kα(λ=0.71069), Space group=P1, Z=2, Final R=0.0793.
17. 2O, 25°C).
18. Sato K., Matsuura Y., Inone M., Une T., Osada Y., Ogawa H., Mitsuhashi S. Antimicrob. Agents. Chemother. 22:1982;548.